
S6.12.3 – After the Semaglutide Approval: What Next For MASH Therapy?
Four leading Key Opinion Leaders join Roger Green to discuss the implications of semaglutide’s approval on MAH therapy in the U.S. This conversation covers the larger, downstream changes we will see in how MASLD and MASH are treated in the U.S.








